Kiniksa Pharmaceuticals International (KNSA) Inventory Average (2021 - 2026)

Kiniksa Pharmaceuticals International's Inventory Average history runs 6 years deep, the most recent figure standing at $64.0 million for Q1 2026.

• Quarterly Inventory Average rose 164.36% year-over-year to $64.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.0 million (up 164.36% YoY) and the FY2025 annual result came in at $40.6 million, up 41.35% from the prior year.
• Inventory Average was $64.0 million for Q1 2026 at Kiniksa Pharmaceuticals International, up from $48.1 million in the prior quarter.
• Across five years, Inventory Average topped out at $64.0 million in Q1 2026 and bottomed at $8.4 million in Q1 2022.
• A 5-year average of $29.2 million and a median of $27.5 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average surged 290.26% — and 2025, when it slipped 17.07%.
• Kiniksa Pharmaceuticals International's Inventory Average stood at $18.1 million in 2022, then soared by 56.56% to $28.4 million in 2023, then fell by 2.93% to $27.5 million in 2024, then surged by 74.93% to $48.1 million in 2025, then jumped by 32.97% to $64.0 million in 2026.
• Business Quant data shows KNSA's Inventory Average at $64.0 million in Q1 2026, $48.1 million in Q4 2025, and $44.8 million in Q3 2025.